Abstract
Coronary heart disease (CHD) is the leading cause of death among postmenopausal women in Western societies. It is generally accepted that CHD risk is reduced by about 50% in postmenopausal women who take conjugated equine estrogens (CEE) daily (Bush 1990; Stampfer and Colditz 1991). Observational studies of postmenopausal women undergoing angiography for chest pain have shown that coronary artery occlusions are fewer among estrogen users than nonusers (Sullivan 1993; Gruchow et al. 1988; Hong et al. 1992). These data suggest that estrogen may reduce CHD risk by affecting atherogenesis. Recent studies have explored the mechanism(s) by which estrogen reduces CHD risk and inhibits atherogenesis. One of the main areas of attention is the potential role of nitric oxide (NO) as an important mediator of estrogen’s effects on coronary artery disease.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Adams MR, Kaplan JR, Manuck SB, Koritnik DR, Parks JS, Wolfe MS, Clarkson TB (1990) Inhibition of coronary artery atherosclerosis by 17 beta-estradiol in ovariectomized monkeys: lack of an effect of added progesterone. Arteriosclerosis 10: 1051–1057
Adams MR, Register TC, Golden DL, Wagner JD, Williams JK (1997) Medroxyprogesterone acetate antagonizes inhibitory effects of conjugated equine estrogens on coronary artery atherosclerosis. Arterioscler Thromb Vasc Biol 17: 217–221
Bush TL (1990) Noncontraceptive estrogen use and risk of cardiovascular disease: an overview and critique of the literature. In: Korenman SG (ed) The menopause: biological and clinical consequences of ovarian failure: evolution and management. Serono Symposia, Norwell, MA, pp 211–224
Cayatte AJ, Palacino JJ, Horten K, Cohen RA (1994) Chronic inhibition of nitric oxide production accelerates ncointima formation and impairs endothelial function in hypercholesterolemic rabbits. Arterioscler Thromb 14: 753–759
Chang W-C, Nakao J, Orimo H, Murota S-L (1980) Stimulation of prostaglandin cyclooxygenase and prostacyclin synthetase activities by estradiol in rat aortic smooth muscle cells. Biochim Biophys Acta 620: 472–482
Clarkson TB, Anthony MS, Klein KP (1996) Hormone replacement therapy and coronary artery atherosclerosis: the monkey model. Br J Obstet Gynaecol 103 [Suppl 131: 53–58
Conrad KP, Joffe GM, Kruszyna H, Kruszyna R, Rochelle LG, Smith RP, Chavez JE, Mosher MD (1993) Identification of increased nitric oxide biosynthesis during pregnancy in rats. FASEB J 7: 566–571
Cooke JP, Singer AH, Tsao P, Zera P, Rowan RA, Billingham ME (1992) Antiatherogenic effects of L-arginine in the hypercholesterolemic rabbit. J Clin Invest 90: 1168–1172
Farhat MY, Vargas R, Dingaan B, Ramwell PW (1992) In vitro effect of oestradiol on thymidine uptake in pulmonary vascular smooth muscle cell: role of the endothelium. Br J Pharmacol 107: 679–683
Fischer-Dzoga K, Wissler R, Vesselinovitch D (1983) The effect of estradiol on the proliferation of rabbit aortic medial tissue cells induced by hyperlipemic serum. Exp Mol Pathol 39: 355–363
Furchgott RF, Zawadski JV (1980) The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine. Nature 288: 373–376
Garg UC, Hassid A (1989) Nitric oxide-generating vasodilators and 8-bromocyclic guanosine monophosphate inhibit mitogenesis and proliferation of cultured rat vascular smooth muscle cells. J Clin Invest 83: 1774–1777
Gisclard V, Flavahan NA, Vanhoutte PM (1987) Alpha adrenergic responses of blood vessels of rabbits after ovariectomy and administration of 17 beta-estradiol. J Pharmacol Exp Ther 240: 466–470
Gisclard V, Miller VM, Vanhoutte PM (1988) Effect of 17 beta-estradiol on endothelium-dependent responses in rabbits. J Pharmacol Exp Ther 244: 19–22
Gruchow HW, Anderson AJ, Barboriak J, Sobocinski VA (1988) Postmenopausal use of estrogen and occlusion of coronary arteries. Am Heart J 115: 954–963
Harder DR, Coulson PB (1979) Estrogen receptors and effects of estrogen on membrane electrical properties of coronary vascular smooth muscle. J Cell Physiol 100: 375–382
Hayashi T, Fukuto JM, Ignarro LJ, Chaudhuri G (1992) Basal release of nitric oxide from aortic rings is greater in female rabbits than male rabbits: Implications for atherosclerosis. Proc Nati Acad Sci USA 89: 11259–11263
Herrington DM, Braden GA, Downes TR, Williams JK (1994) Estrogen modulates coronary vasomotor responses in postmenopausal women with early atherosclerosis. Am J Cardiol 73: 951–952
Hill CH, Pullman EP, Starcher B, Shih JCH (1995) Dietary nitroprusside alleviates atherosclerosis in hypercholesterolemic Japanese quail ( Coturnix japonica ). Comp Biochem Physiol 112A: 151–154
Hong MK, Romm PA, Reagan K, Green CE, Rackley CE (1992) Effects of estrogen replacement therapy on serum lipid values and angiographically defined coronary artery disease in postmenopausal women. Am J Cardiol 69: 176–178
Jiang C, Sarrel PM, Lindsay DC, Poole-Wilson PA, Collins P (1991) Endothelium-independent relaxation of rabbit coronary artery by 17-beta estradiol. Br J Pharmacol 104: 1033–1037
Jiang C, Sarrel PM, Poole-Wilson PA, Collins P (1992) Acute effect of 17 beta-estradiol on rabbit coronary artery contractile responses to endothelin1. Am J Physiol 263: H271 — H275
Johnson G, Tsao PS, Malloy D, Lefer AM (1990) Cardioprotective effects of acidified sodium nitrite in myocardial ischemia with reperfusion. J Pharmacol Exp Ther 252: 35–41
Kubes P, Suzuki M, Granger DN (1991) Nitric oxide: an endogenous modulator of leukocyte adhesion. Proc Natl Acad Sci USA 88: 4651–4655
Ludmer PL, Selwyn AP, Shook TL, Wayne RR, Mudge GH, Alexander RW, Ganz P (1986) Paradoxical vasoconstriction induced by acetylcholine in atherosclerotic coronary arteries. N Engl J Med 315: 1046–1051
MacKenzie JN (1884) Irritation of the sexual apparatus. Am J Med Sci 87: 360–365
Mendelsohn ME, Karas RH (1994) Estrogen and the blood vessel wall. Curr Opin Cardiol 9: 619–626
Miller VM, Gisclard V, Vanhoutte PM (1988) Modulation of endothelium-dependent and vascular smooth muscle responses by oestrogens. Phlebology 3 [Suppl 11: 63–69
Naruse K, Shimizu K, Muramatsu M, Toki Y, Miyazaki Y, Okumura K, Hashimoto H, Ito T (1994) Long-term inhibition of NO synthesis promotes atherosclerosis in hypercholesterolemic rabbit thoracic aorta. Arterioscler Thromb 14: 746–752
Palmer RMJ, Ferrige AG, Moncada S (1987) Nitric oxide release accounts for the biologic activity of endothelium-derived relaxing factor. Nature 327: 524–526
Radamski MW, Palmer RMJ, Moncada S (1990) An L-arginine/nitric oxide pathway present in human platelets regulates aggregation. Proc Natl Acad Sci USA 87: 5193–5197
Reis SE, Gloth ST, Blumenthal RS, Resar JR, Zacur HA, Gerstenblith G, Brinker JA (1994) Ethinyl estradiol acutely attenuates abnormal coronary vasomotor responses to acetylcholine in postmenopausal women. Circulation 89: 52–60
Reynolds SRM, Foster FI (1940) Peripheral vascular action of estrogen observed in the ear of the rabbit. J Pharmacol Exp Ther 68: 173–177
Silva de Sa MF, Meirelles RS (1977) Vasodilation effect of estrogen on the human umbilical artery. Gynecol Invest 8: 307–313
Stamler J, Mendelsohn ME, Amarante P, Smick D, Andon N, Davies PF, Cooke JP, Loscalzo J (1989) N-acetylcysteine potentiates platelet inhibition by endothelium-derived relaxing factor. Circ Res 65: 789–795
Stampfer MJ, Colditz GA (1991) Estrogen replacement and coronary heart disease: a quantitative assessment of the epidemiologic evidence. Prey Med 20: 47–63
Sullivan JM (1993) Hormone replacement in the secondary prevention of cardiovascular disease. In: Wenger NK, Speroff L, Packard B (eds) Cardiovascular health and disease in women. Proceedings of an NHLBI conference. LeJacq Communications, Greenwich, CT, pp 189–194
Ueland K, Parer JT (1966) Effects of estrogens on the cardiovascular system of the ewe. Am J Obstet Gynecol 96: 400–406
Vargas R, Wroblewska B, Rego A, Hatch J, Ramwell PW (1993) Oestradiol inhibits smooth muscle cell proliferation of pig coronary artery. Br J Pharmacol 109: 612–617
Wagner JD, Clarkson TB, St Clair RW, Schwenke DC, Shively CA, Adams MR (1991) Estrogen and progesterone replacement therapy reduces LDL accumulation in the coronary arteries of surgically postmenopausal cynomolgus monkeys. J Clin Invest 88: 1995–2002
Weiner CP, Lizasoian L, Baylis SA, Knowles RG, Charles IG, Moncada S (1994) Induction of calcium-dependent nitric oxide synthesis by sex hormones. Proc Natl Acad Sci USA 91: 5212–5216
Williams JK, Adams MR, Klopfenstein HS (1990) Estrogen modulates re- sponses of atherosclerotic coronary arteries. Circulation 81: 1680–1687
Williams JK, Adams MR, Herrington DM, Clarkson TB (1992) Short-term administration of estrogen and vascular responses of atherosclerotic coronary arteries. J Am Coll Cardiol 20: 452–457
Zhang R, Ram JL, Standley PR, Sowers JR (1994) 17 beta-estradiol attenuates voltage-dependent Ca currents in A7r5 vascular smooth muscle line. Am J Physiol 266: C975 — C980
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1997 Springer-Verlag Berlin Heidelberg
About this paper
Cite this paper
Williams, J.K., Adams, M.R., Clarkson, T.B. (1997). Estrogen, Nitric Oxide, and Primate Atherosclerosis. In: Lancaster, J.R., Parkinson, J.F. (eds) Nitric Oxide, Cytochromes P450, and Sexual Steroid Hormones. Ernst Schering Research Foundation Workshop, vol 21. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-662-03503-0_10
Download citation
DOI: https://doi.org/10.1007/978-3-662-03503-0_10
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-662-03505-4
Online ISBN: 978-3-662-03503-0
eBook Packages: Springer Book Archive